Ravulizumab - Latest Advances

Progress in the use of biological therapies to treat paroxysmal nocturnal hemoglobinuria: focus on patient profiling.

Journal: Expert opinion on biological therapy

Published: October 13, 2025

Challenges in optimizing targeted complement inhibitor therapy for paroxysmal nocturnal hemoglobinuria in an expanding treatment landscape

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: October 01, 2025

New treatment strategies for paroxysmal nocturnal hemoglobinuria: drug selection in the era of novel complement inhibitors

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 03, 2025

Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?

Journal: Journal of the American Society of Nephrology : JASN

Published: August 22, 2025

Authors' Reply: Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?

Journal: Journal of the American Society of Nephrology : JASN

Published: August 22, 2025

First reported case of Moraxella lacunata bacteremia following pharyngitis in an adult with paroxysmal nocturnal hemoglobinemia receiving ravulizumab: A case report.

Journal: IDCases

Published: August 04, 2025

Clinical and Serological Profile of Myasthenia Gravis in the O'Higgins Region of Chile: A Regional Study.

Journal: Cureus

Published: July 26, 2025

Transplacental transfer of ravulizumab in a pregnant woman with neuromyelitis optica: a case report.

Journal: BMJ neurology open

Published: July 23, 2025

Successful Control of Chemotherapy-Induced Breakthrough Hemolysis With Ravulizumab in a Patient With Paroxysmal Nocturnal Hemoglobinuria During Carboplatin-Pemetrexed Treatment for Lung Adenocarcinoma.

Journal: Cureus

Published: July 18, 2025

Neuromuscular junction and the complement system.

Journal: International review of neurobiology

Published: July 17, 2025

Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience.

Journal: American journal of hematology

Published: July 17, 2025

Successful treatment of severe IVIG-induced immune hemolytic anemia with ravulizumab in a patient with systemic lupus erythematosus: a therapeutic challenge.

Journal: Rheumatology (Oxford, England)

Published: July 09, 2025

Filters

Progress in the use of biological therapies to treat paroxysmal nocturnal hemoglobinuria: focus on patient profiling.

Progress in the use of biological therapies to treat paroxysmal nocturnal hemoglobinuria: focus on patient profiling.

Challenges in optimizing targeted complement inhibitor therapy for paroxysmal nocturnal hemoglobinuria in an expanding treatment landscape

Challenges in optimizing targeted complement inhibitor therapy for paroxysmal nocturnal hemoglobinuria in an expanding treatment landscape

New treatment strategies for paroxysmal nocturnal hemoglobinuria: drug selection in the era of novel complement inhibitors

New treatment strategies for paroxysmal nocturnal hemoglobinuria: drug selection in the era of novel complement inhibitors

Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?

Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?

Authors' Reply: Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?

Authors' Reply: Ravulizumab in IgA Nephropathy: A Promising Step Toward Disease Modification?

First reported case of Moraxella lacunata bacteremia following pharyngitis in an adult with paroxysmal nocturnal hemoglobinemia receiving ravulizumab: A case report.

First reported case of Moraxella lacunata bacteremia following pharyngitis in an adult with paroxysmal nocturnal hemoglobinemia receiving ravulizumab: A case report.

Clinical and Serological Profile of Myasthenia Gravis in the O'Higgins Region of Chile: A Regional Study.

Clinical and Serological Profile of Myasthenia Gravis in the O'Higgins Region of Chile: A Regional Study.

Transplacental transfer of ravulizumab in a pregnant woman with neuromyelitis optica: a case report.

Transplacental transfer of ravulizumab in a pregnant woman with neuromyelitis optica: a case report.

Successful Control of Chemotherapy-Induced Breakthrough Hemolysis With Ravulizumab in a Patient With Paroxysmal Nocturnal Hemoglobinuria During Carboplatin-Pemetrexed Treatment for Lung Adenocarcinoma.

Successful Control of Chemotherapy-Induced Breakthrough Hemolysis With Ravulizumab in a Patient With Paroxysmal Nocturnal Hemoglobinuria During Carboplatin-Pemetrexed Treatment for Lung Adenocarcinoma.

Neuromuscular junction and the complement system.

Neuromuscular junction and the complement system.

Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience.

Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience.

Successful treatment of severe IVIG-induced immune hemolytic anemia with ravulizumab in a patient with systemic lupus erythematosus: a therapeutic challenge.

Successful treatment of severe IVIG-induced immune hemolytic anemia with ravulizumab in a patient with systemic lupus erythematosus: a therapeutic challenge.